Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
RadNet’s $259.2 Million Common Stock Public Offering
Sheppard Mullin represented RadNet, and Latham & Watkins represented the underwriters. RadNet, Inc. (NASDAQ: RDNT) has announced the closing of its underwritten public offering of 8,711,250 shares...
Nikola Corporation’s $144 Million Acquisition of Romeo Power
Pillsbury Winthrop Shaw Pittman represented Nikola, while Latham & Watkins represented Romeo Power in the transaction. Nikola Corporation (NASDAQ: NKLA), and Romeo Power, Inc. (NYSE: RMO), have...
Anthemis Digital Acquisitions I Corp’s $200 Million Initial Public Offering
Latham & Watkins represented Anthemis SPAC in the offering. Anthemis Digital Acquisitions I Corp has announced the pricing of its initial public offering of 20,000,000 units...
GitLab’s $800 Million Initial Public Offering
Fenwick represented GitLab Inc. on the deal, while Latham & Watkins represented the underwriters. GitLab Inc. (Nasdaq: GTLB), provider of The DevOps Platform, announced its initial public...
EngageSmart’s $378 Million IPO
Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading...
Zeta’s Initial Public Offering
Latham & Watkins LLP represented Zeta, while Skadden, Arps, Slate, Meagher & Flom LLP advised the joint lead book-running managers in the offering. Zeta launched its initial public...